Lloyd B Mulenga

Datos Biográficos

ID8934242
NOMBRELloyd B Mulenga
NOMBRESLloyd B
APELLIDOMulenga
FIRMAMULENGA L B
AFILIACIONESZambia Ministry of Health, Lusaka, Zambia
VERIFICADONo
TOTAL DE OBRAS6
TOTAL DE CITAS0
TOTAL COMO AUTOR6
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Patterns of engagement in care during clients’ first 12 months after HIV treatment initiation in Zambia

    Open AccessMariet Benade, Mhairi Maskew et al.ARTICLEBMJ Global Health2025

    BACKGROUND: The first year after HIV treatment initiation or re-initiation is the period of highest risk of a treatment interruption or disengagement, yet little is known about the timing, patterns and effects of interruptions in the early treatment period. METHODS: Using routinely collected electronic medical record data from 543 Zambian facilities from 2018 to 2023, we described patterns of engagement during the first year of HIV treatment. We …

  • Implementing Sars-CoV-2 routine surveillance in antenatal care in Zambia, 2021–2022

    Open AccessTannia Tembo, Elizabeth Heilmann et al.ARTICLEBMC Public Health2025

    Incorporating SARS-CoV-2 surveillance into routine antenatal care is feasible and potentially sustainable when existing health system infrastructure, human resources, and surveillance systems are leveraged. Yet, careful planning is needed to anticipate implementation challenges and ensure high-quality data collection

  • Trends in Sars-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia

    Open AccessElizabeth Heilmann, Tannia Tembo et al.ARTICLEPLOS Global Public Health2024

    SARS-CoV-2 serosurveys help estimate the extent of transmission and guide the allocation of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women attending ANC clinics to assess exposure trends over time in Zambia. We conducted repeated cross-sectional SARS-CoV-2 seroprevalence surveys among pregnant women aged 15–49 years attending their first ANC visits in four districts of Zambia (two urban and two rural) during September 2021-S…

  • Hypertension among persons living with HIV—Zambia, 2021; A cross-sectional study of a national electronic health record system

    Open AccessJonas Z Hines, 守夫 西田 et al.ARTICLEPLOS Global Public Health2023

    Hypertension is a major risk factor for cardiovascular disease, which is a common cause of death in Zambia. Data on hypertension prevalence in Zambia are scarce and limited to specific geographic areas and/or populations. We measured hypertension prevalence among persons living with HIV (PLHIV) in Zambia using a national electronic health record (EHR) system. We did a cross-sectional study of hypertension prevalence among PLHIV aged ≥18 years dur…

  • Intersection of alcohol use, HIV infection, and the HIV care continuum in Zambia

    Michael J Vinikoor, Izukanji Sikazwe et al.ARTICLEAIDS Care2023

    Through a nationally-representative household survey, we measured the prevalence and correlates of unhealthy alcohol use (UAU) in Zambia and its association with the HIV care continuum. Adolescent and adult (ages 15–59 years) data, including the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C), from the 2016 Zambia Population-based HIV Impact Assessment, were analyzed. UAU was defined as AUDIT-C of 3 + points for women and 4 + for …

  • Prevalence of and factors associated with late diagnosis of HIV in Malawi, Zambia, and Zimbabwe

    Open AccessAndreas D Haas, Elizabeth Radin et al.ARTICLEPLOS Global Public Health2022

    Introduction Late diagnosis of HIV (LD) increases the risk of morbidity, mortality, and HIV transmission. We used nationally representative data from population-based HIV impact assessment (PHIA) surveys in Malawi, Zambia, and Zimbabwe (2015–2016) to characterize adults at risk of LD and to examine associations between LD and presumed HIV transmission to cohabiting sexual partners. Methods We estimated the prevalence of LD, defined as CD4 count R…